Kim explained during the radio interview that 2017 would be the earliest that one of its leading vaccines would go to market and produce revenue. If so, where do the astute investors on this board think the price will be 3 years from now?
I was hoping that INO would follow a similar path as ACAD, where the pps rose from $2 to a high near $30
last year. It's leading product, if all goes well, could start producing revenues in 2015. Undoubtedly, it's current price at $24 will increase if it receives final approval. I don't expect INO to mimic ACAD anymore but it just seems to be undervalued given its robust pipeline and strong management team. Maybe the true stumbling
block is the lack of a Phase 3 trial.
That's fair. We are all here to make money. I have a small long position and looking to sell at some point as I see better opportunities elsewhere. INO is my largest holding and that's one that you don't want to short, at least at current levels.
So, why are you here? Did you short the stock or are you looking to buy under$6?
You come across as nervous and not so confident with all your posts. People who are insecure seem to talk a lot. Truly, if you are that experienced, you wouldn't waste your time on here.
The dead cat headline is meaningless. It applies to any stock that falls and rises by a leading percentage.if you trade based on this information alone, you are an idiot.
On the positive side, it just gives more exposure to INO and potential investors.
The news this morning was a dagger in your heart, wasn't it? It made you want to wretch. Now you have to suffer watching the next run and your holiday weekend has been ruined because this is going to consume you and eat away at you.
There are always traders and flippers. The more volatility in stock price, the more traders who come in to make quick profits. Once they leave and this settles down, the pps will establish a new, higher base and stay within a tight trading g range until significant news is released.
What did you expect? They laid out everything happening for shareholders to get a complete picture. The ZTE detailed activity in Feb was new. Put it on the website and you can't ask questions. This is for the long term investor. Buy and hold for five years and see where the pps will be. Should beat the overall market easily.
Will likely close down tomorrow as traders close positions. Should settle into a fairly tight range around $4 until there's significant news.
VRNG IS behaving like a biotech stock because legal proceedings can take years just like clinical trials.
ZTE has to be scared after Vringo beat Google. Management talked today about how they are putting the hammer to ZTE in different countries. ZTE India must really be sweating...
Microsoft has proven to be the smartest defendant so far. They actually settled.
If you don't settle with Vringo, you will pay in the end. If you drag it out like Google is doing, you just end up paying more in the long run. Other companies who will be sued in the future will be more likely to settle and not
take on Vringo in court.
Agreed..No announcement tomorrow, just bell ringing. Would rather see the pps gradually move up
and find subsequent support levels. Let's have the next significant news when the pps is in the $3.50 to
I think we see an initial spike before it settles and closes down for the day...around $2.75. I don't believe there will be any announcements other than the bell ringing.
Nothing new from today. This will drop back to $2.50 again. A very disappointing day for longs.
It's like they got their bell rung or something...
At some point, Google just needs to concede and move on. Every appeal and ruling against them just makes them look even more foolish and Vringo gets more attention .
This sat in the .40s for a long time. When it more than doubled, some are naturally taking their profits..once the majority of those types of trades are finished, this will move up...rather see 4-6% weekly gains then a huge breakout followed by sell-offs--but I am a longer term investor as opposed to a trader.